Skip to content
Home/Companies/Biotech/Corat Therapeutics GmbH
Corat Therapeutics GmbH

Corat Therapeutics GmbH

Biotech·Germany·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Corat Therapeutics GmbH?

Corat Therapeutics GmbH is a German Biotech company, currently owned by NBank Capital since 2020.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
NBank Capital
Investor
NBank Capital
NBank Capital Beteiligungsfonds · 2009 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive
Websitecorat-therapeutics.com

More from NBank Capital Beteiligungsfonds

Other portfolio companies in the same fund.

ALL About Midlife
Active
Germany· 2026
FEHRMANN MaterialsX GmbH
Active
Germany· 2026
Herodikos
Active
Germany· 2026
BIOWEG GmbH
Active
ClimateTechGermany· 2025
heyGuide (formerly heyParents)
Active
Germany· 2025
LBR Manufacturing GmbH
Active
Germany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Corat Therapeutics GmbH?

Corat Therapeutics GmbH is currently owned by NBank Capital, through NBank Capital Beteiligungsfonds, since 2020.

When did NBank Capital acquire Corat Therapeutics GmbH?

NBank Capital acquired Corat Therapeutics GmbH in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue